TrialClinical genitourinary cancer2019

COMPARZ Post Hoc Analysis: Characterizing Pazopanib Responders With Advanced Renal Cell Carcinoma.

Cora N Sternberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.